146 related articles for article (PubMed ID: 36757170)
21. Hematopoietic Stem Cell Transplant in Adolescent and Young Adults With Fanconi Anemia Is Feasible With Acceptable Toxicity, With Those Surviving 100 Days Posttransplant Having Excellent Outcomes.
Alhuraiji A; Alzahrani H; Al Mohareb F; Chaudhri N; Alsharif F; Mohamed S; Rasheed W; Aldawsari G; Ahmed SO; Aljurf M
Exp Clin Transplant; 2016 Dec; 14(6):660-664. PubMed ID: 27447289
[TBL] [Abstract][Full Text] [Related]
22. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.
Cotter PD; May A; Fitzsimons EJ; Houston T; Woodcock BE; al-Sabah AI; Wong L; Bishop DF
J Clin Invest; 1995 Oct; 96(4):2090-6. PubMed ID: 7560104
[TBL] [Abstract][Full Text] [Related]
23. [Haploidentical allogenetic hematopoietic stem cell transplantation for X-linked adrenoleukodystrophy].
Chen Y; Zhang XH; Xu LP; Liu KY; Qin J; Yang YL; Huang XJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Jun; 51(3):409-413. PubMed ID: 31209410
[TBL] [Abstract][Full Text] [Related]
24. Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.
Hsieh MM; Fitzhugh CD; Weitzel RP; Link ME; Coles WA; Zhao X; Rodgers GP; Powell JD; Tisdale JF
JAMA; 2014 Jul; 312(1):48-56. PubMed ID: 25058217
[TBL] [Abstract][Full Text] [Related]
25. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of matched sibling donor hematopoietic stem cell transplantation for severe sickle cell disease with myeloablative conditioning and intermediate-dose of rabbit anti-thymocyte globulin.
Soni S; Gross TG; Rangarajan H; Baker KS; Sturm M; Rhodes M
Pediatr Blood Cancer; 2014 Sep; 61(9):1685-9. PubMed ID: 24740582
[TBL] [Abstract][Full Text] [Related]
27. Goal-Oriented Monitoring of Cyclosporine Is Effective for Graft-versus-Host Disease Prevention after Hematopoietic Stem Cell Transplantation in Sickle Cell Disease and Thalassemia Major.
Gauthier A; Bleyzac N; Garnier N; Kebaili K; Joly P; Goutagny MP; Mollet I; Goutelle S; Renard C; Bertrand Y
Biol Blood Marrow Transplant; 2020 Dec; 26(12):2285-2291. PubMed ID: 32007639
[TBL] [Abstract][Full Text] [Related]
28. Pyridoxine-refractory congenital sideroblastic anaemia with evidence for autosomal inheritance: exclusion of linkage to ALAS2 at Xp11.21 by polymorphism analysis.
Jardine PE; Cotter PD; Johnson SA; Fitzsimons EJ; Tyfield L; Lunt PW; Bishop DF
J Med Genet; 1994 Mar; 31(3):213-8. PubMed ID: 7912287
[TBL] [Abstract][Full Text] [Related]
29. Stable long-term donor engraftment following reduced-intensity hematopoietic cell transplantation for sickle cell disease.
Krishnamurti L; Kharbanda S; Biernacki MA; Zhang W; Baker KS; Wagner JE; Wu CJ
Biol Blood Marrow Transplant; 2008 Nov; 14(11):1270-8. PubMed ID: 18940682
[TBL] [Abstract][Full Text] [Related]
30. Clinical and genetic characteristics of congenital sideroblastic anemia: comparison with myelodysplastic syndrome with ring sideroblast (MDS-RS).
Ohba R; Furuyama K; Yoshida K; Fujiwara T; Fukuhara N; Onishi Y; Manabe A; Ito E; Ozawa K; Kojima S; Ogawa S; Harigae H
Ann Hematol; 2013 Jan; 92(1):1-9. PubMed ID: 22983749
[TBL] [Abstract][Full Text] [Related]
31. Hereditary sideroblastic anemia: pathophysiology and gene mutations.
Harigae H; Furuyama K
Int J Hematol; 2010 Oct; 92(3):425-31. PubMed ID: 20848343
[TBL] [Abstract][Full Text] [Related]
32. Successful Outcome With Fludarabine-Based Conditioning Regimen for Hematopoietic Stem Cell Transplantation From Related Donor in Fanconi Anemia: A Single Center Experience From Turkey.
Kuşkonmaz B; Ünal Ş; Bayhan T; Aytaç Eyüboğlu S; Tavil B; Çetin M; Gümrük F; Uçkan Çetinkaya D
Pediatr Blood Cancer; 2016 Apr; 63(4):695-700. PubMed ID: 26703084
[TBL] [Abstract][Full Text] [Related]
33. Novel mutations in mitochondrial carrier family gene SLC25A38, causing congenital sideroblastic anemia in Iranian families, identified by whole exome sequencing.
Mehri M; Zarin M; Ardalani F; Najmabadi H; Azarkeivan A; Neishabury M
Blood Cells Mol Dis; 2018 Jul; 71():39-44. PubMed ID: 29499877
[TBL] [Abstract][Full Text] [Related]
34. [Efficacy of Nonmyeloablative Allogeneic Hematopoietic Stem Cells for 14 Case of Severe Acquired Aplastic Anemia].
Wang SF; Huang YJ; Yu CL; Sun QY; Qiao JH; Hu KX; Zuo HL; Dong Z; Liu ZQ; Wang Y; Huang XM; Ai HS; Guo M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):1097-102. PubMed ID: 26314453
[TBL] [Abstract][Full Text] [Related]
35. Allogeneic hematopoietic stem cell transplantation in children with aplastic anemia.
Xue HM; Xu HG; Huang K; Guo HX; Li Y; Zhou DH; Huang SL; Fang JP; Chen C
Genet Mol Res; 2015 May; 14(2):5234-45. PubMed ID: 26125718
[TBL] [Abstract][Full Text] [Related]
36. Transplant in Aplastic Anemia Using Combined Granulocyte Colony-Stimulating Factor Primed Blood and Bone Marrow Stem Cells: A Retrospective Analysis.
Ali N; Butt A; Altaf B; Adil SN; Shaikh MU
Transplant Proc; 2021; 53(1):386-390. PubMed ID: 32773285
[TBL] [Abstract][Full Text] [Related]
37. [Fludarabine-based increased-intensity conditioning regimen for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia].
Sun C; Lin X; Huang Y; Song C; Tao Y; Tu S; Fang J; Chen T; Sun C; Wu B
Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):221-4. PubMed ID: 24666488
[TBL] [Abstract][Full Text] [Related]
38. Luspatercept for the treatment of congenital sideroblastic anemia: Two case reports.
Shao Y; He L; Ding S; Fu R
Curr Res Transl Med; 2024 Mar; 72(1):103438. PubMed ID: 38244303
[TBL] [Abstract][Full Text] [Related]
39. Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
Lee KH; Lee JH; Lee JH; Kim DY; Park HS; Choi EJ; Ko SH; Seol M; Lee YS; Kang YA; Jeon M; Baek S; Kang YL; Kim SH; Yun SC; Kim H; Jo JC; Choi Y; Joo YD; Lim SN
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1555-1566. PubMed ID: 28552421
[TBL] [Abstract][Full Text] [Related]
40. Hereditary sideroblastic anemias: pathophysiology, diagnosis, and treatment.
Camaschella C
Semin Hematol; 2009 Oct; 46(4):371-7. PubMed ID: 19786205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
